Authors of this study reported that sodium butyrate and trichostatin A, two structurally different HDAC inhibitors, significantly inhibited the expression of TJ protein claudin-1 in colon cancer cells, seemingly through the modulation of claudin-1 mRNA stability. Here, CLDN1 is linked to colonic neoplasm.